Medica Sur - Public Comps and Valuation Multiples

Medica Sur Overview

About Medica Sur

Medica Sur SAB de CV is a medical care company specializes in emergency scenarios. The company offers emergency ambulance transportation, air transportation and paramedic assistance.

Founded

1966

HQ

Employees

3.5K+

Website

medicasur.com.mx

Sectors

Hospitals & Clinics

Financials

LTM Revenue $253M

LTM EBITDA $51.8M

EV

$232M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Medica Sur Financials

As of September 2025, Medica Sur reported last 12-month revenue of $253M and EBITDA of $51.8M.

In the same period, Medica Sur generated $89.7M in LTM gross profit and $28.9M in net income.

See Medica Sur valuation multiples based on analyst estimates

Medica Sur P&L

In the most recent fiscal year, Medica Sur reported revenue of $238M and EBITDA of $46.7M.

Medica Sur expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Medica Sur valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$253M	XXX	$238M	XXX	XXX	XXX
Gross Profit	$89.7M	XXX	$80.7M	XXX	XXX	XXX
Gross Margin	35%	XXX	34%	XXX	XXX	XXX
EBITDA	$51.8M	XXX	$46.7M	XXX	XXX	XXX
EBITDA Margin	20%	XXX	20%	XXX	XXX	XXX
EBIT	$40.3M	XXX	$34.3M	XXX	XXX	XXX
EBIT Margin	16%	XXX	14%	XXX	XXX	XXX
Net Profit	$28.9M	XXX	$25.0M	XXX	XXX	XXX
Net Margin	11%	XXX	10%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Medica Sur including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $253M. EBITDA for the last twelve months was $51.8M. In the most recent fiscal year, Medica Sur achieved $238M in revenue and $46.7M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$253M	Analyst estimates available to subscribers	$238M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$89.7M	Analyst estimates available to subscribers	$80.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	35.4% gross margin	Analyst estimates available to subscribers	33.9% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$51.8M	Analyst estimates available to subscribers	$46.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	20.5% EBITDA margin	Analyst estimates available to subscribers	19.6% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$40.3M	Analyst estimates available to subscribers	$34.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	15.9% EBIT margin	Analyst estimates available to subscribers	14.4% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$28.9M	Analyst estimates available to subscribers	$25.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	11.4% net profit margin	Analyst estimates available to subscribers	10.5% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Medica Sur

This financial data table provides comprehensive performance metrics for Medica Sur, a company based in Mexico. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Medica Sur generated $253M in revenue over the last twelve months.
The company achieved $51.8M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $89.7M.
Net income over the last twelve months reached $28.9M.

Fiscal Year Performance

In the most recent fiscal year, Medica Sur reported $238M in total revenue.
Fiscal year EBITDA was $46.7M.
The company maintained a gross profit margin of 33.9% in the most recent fiscal year.
EBITDA margin for the fiscal year was 19.6%.
Net profit margin reached 10.5% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Medica Sur. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Medica Sur Stock Performance

Medica Sur has current market cap of MXN 4.4B (or $237M), and EV of MXN 4.3B (or $232M).

Market Cap Evolution

Medica Sur Stock Data

As of October 2, 2025, Medica Sur's stock price is MXN 46 (or $2).

See Medica Sur trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$232M	$237M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Medica Sur Valuation Multiples

Medica Sur's trades at 1.0x EV/Revenue multiple, and 5.0x EV/EBITDA.

See valuation multiples for Medica Sur and 15K+ public comps

Medica Sur Financial Valuation Multiples

As of October 2, 2025, Medica Sur has market cap of $237M and EV of $232M.

Equity research analysts estimate Medica Sur's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Medica Sur has a P/E ratio of 8.2x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$237M	XXX	$237M	XXX	XXX	XXX
EV (current)	$232M	XXX	$232M	XXX	XXX	XXX
EV/Revenue	0.9x	XXX	1.0x	XXX	XXX	XXX
EV/EBITDA	4.5x	XXX	5.0x	XXX	XXX	XXX
EV/EBIT	5.8x	XXX	6.8x	XXX	XXX	XXX
EV/Gross Profit	2.6x	XXX	n/a	XXX	XXX	XXX
P/E	8.2x	XXX	9.5x	XXX	XXX	XXX
EV/FCF	n/a	XXX	6.5x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Medica Sur Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Medica Sur Margins & Growth Rates

Medica Sur's last 12 month revenue growth is 7%

Medica Sur's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $13K for the same period.

Medica Sur's rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Medica Sur's rule of X is 37% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Medica Sur and other 15K+ public comps

Medica Sur Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	7%	XXX	7%	XXX	XXX	XXX
EBITDA Margin	20%	XXX	20%	XXX	XXX	XXX
EBITDA Growth	10%	XXX	1%	XXX	XXX	XXX
Rule of 40	31%	XXX	26%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	37%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$13K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	19%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial